Intuitive Surgical Gross Margin 2012-2025 | ISRG
Current and historical gross margin for Intuitive Surgical (ISRG) over the last 10 years. The current gross profit margin for Intuitive Surgical as of December 31, 2025 is %.
| Intuitive Surgical Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-12-31 | $10.06B | $6.64B | 66.00% |
| 2025-09-30 | $9.61B | $6.38B | 66.38% |
| 2025-06-30 | $9.15B | $6.09B | 66.62% |
| 2025-03-31 | $8.72B | $5.85B | 67.09% |
| 2024-12-31 | $8.35B | $5.63B | 67.45% |
| 2024-09-30 | $7.87B | $5.27B | 66.98% |
| 2024-06-30 | $7.57B | $5.06B | 66.84% |
| 2024-03-31 | $7.32B | $4.86B | 66.42% |
| 2023-12-31 | $7.12B | $4.73B | 66.38% |
| 2023-09-30 | $6.85B | $4.56B | 66.60% |
| 2023-06-30 | $6.66B | $4.45B | 66.75% |
| 2023-03-31 | $6.43B | $4.30B | 66.86% |
| 2022-12-31 | $6.22B | $4.20B | 67.44% |
| 2022-09-30 | $6.12B | $4.15B | 67.77% |
| 2022-06-30 | $5.96B | $4.07B | 68.16% |
| 2022-03-31 | $5.91B | $4.07B | 68.85% |
| 2021-12-31 | $5.71B | $3.96B | 69.33% |
| 2021-09-30 | $5.49B | $3.79B | 69.13% |
| 2021-06-30 | $5.16B | $3.55B | 68.70% |
| 2021-03-31 | $4.55B | $3.03B | 66.49% |
| 2020-12-31 | $4.36B | $2.86B | 65.63% |
| 2020-09-30 | $4.31B | $2.86B | 66.41% |
| 2020-06-30 | $4.36B | $2.92B | 67.07% |
| 2020-03-31 | $4.61B | $3.18B | 69.03% |
| 2019-12-31 | $4.48B | $3.11B | 69.46% |
| 2019-09-30 | $4.25B | $2.95B | 69.47% |
| 2019-06-30 | $4.04B | $2.81B | 69.46% |
| 2019-03-31 | $3.85B | $2.68B | 69.59% |
| 2018-12-31 | $3.73B | $2.60B | 69.91% |
| 2018-09-30 | $3.57B | $2.50B | 70.08% |
| 2018-06-30 | $3.46B | $2.43B | 70.23% |
| 2018-03-31 | $3.31B | $2.33B | 70.34% |
| 2017-12-31 | $3.14B | $2.20B | 70.15% |
| 2017-09-30 | $3.01B | $2.10B | 69.79% |
| 2017-06-30 | $2.88B | $2.02B | 70.01% |
| 2017-03-31 | $2.79B | $1.96B | 70.13% |
| 2016-12-31 | $2.71B | $1.89B | 69.93% |
| 2016-09-30 | $2.63B | $1.82B | 69.41% |
| 2016-06-30 | $2.53B | $1.73B | 68.36% |
| 2016-03-31 | $2.45B | $1.65B | 67.28% |
| 2015-12-31 | $2.39B | $1.58B | 66.21% |
| 2015-09-30 | $2.31B | $1.51B | 65.41% |
| 2015-06-30 | $2.27B | $1.48B | 65.02% |
| 2015-03-31 | $2.20B | $1.44B | 65.26% |
| 2014-12-31 | $2.13B | $1.41B | 66.28% |
| 2014-09-30 | $2.10B | $1.42B | 67.43% |
| 2014-06-30 | $2.05B | $1.41B | 68.91% |
| 2014-03-31 | $2.12B | $1.48B | 69.61% |
| 2013-12-31 | $2.27B | $1.59B | 70.38% |
| 2013-09-30 | $2.30B | $1.63B | 71.11% |
| 2013-06-30 | $2.34B | $1.67B | 71.33% |
| 2013-03-31 | $2.30B | $1.65B | 71.81% |
| 2012-12-31 | $2.18B | $1.57B | 72.05% |
| 2012-09-30 | $2.07B | $1.50B | 72.33% |
| 2012-06-30 | $1.98B | $1.43B | 72.42% |
| 2012-03-31 | $1.87B | $1.35B | 72.49% |
| 2011-12-31 | $1.76B | $1.28B | 72.53% |
| 2011-09-30 | $1.65B | $1.19B | 72.36% |
| 2011-06-30 | $1.55B | $1.12B | 72.33% |
| 2011-03-31 | $1.47B | $1.07B | 72.62% |
| 2010-12-31 | $1.41B | $1.03B | 72.97% |
| 2010-09-30 | $1.35B | $0.98B | 72.90% |
| 2010-06-30 | $1.28B | $0.93B | 72.49% |
| 2010-03-31 | $1.19B | $0.86B | 72.34% |
| 2009-12-31 | $1.05B | $0.75B | 71.39% |
| 2009-09-30 | $0.96B | $0.68B | 71.07% |
| 2009-06-30 | $0.92B | $0.65B | 71.32% |
| 2009-03-31 | $0.88B | $0.62B | 70.86% |
| 2008-12-31 | $0.88B | $0.62B | 70.97% |
| 2008-09-30 | $0.83B | $0.59B | 71.03% |
| 2008-06-30 | $0.75B | $0.53B | 70.25% |
| 2008-03-31 | $0.67B | $0.47B | 69.29% |
| 2007-12-31 | $0.60B | $0.41B | 69.00% |
| 2007-09-30 | $0.52B | $0.35B | 67.56% |
| 2007-06-30 | $0.46B | $0.31B | 66.52% |
| 2007-03-31 | $0.41B | $0.27B | 66.59% |
| 2006-12-31 | $0.37B | $0.25B | 66.49% |
| 2006-09-30 | $0.33B | $0.22B | 66.87% |
| 2006-06-30 | $0.30B | $0.20B | 68.01% |
| 2006-03-31 | $0.26B | $0.18B | 68.06% |
| 2005-12-31 | $0.23B | $0.15B | 67.54% |
| 2005-09-30 | $0.20B | $0.14B | 67.16% |
| 2005-06-30 | $0.18B | $0.12B | 66.29% |
| 2005-03-31 | $0.15B | $0.10B | 65.36% |
| 2004-12-31 | $0.14B | $0.09B | 64.49% |
| 2004-09-30 | $0.12B | $0.07B | 57.02% |
| 2004-06-30 | $0.11B | $0.06B | 53.21% |
| 2004-03-31 | $0.10B | $0.05B | 51.52% |
| 2003-12-31 | $0.09B | $0.05B | 49.45% |
| 2003-09-30 | $0.08B | $0.04B | 51.19% |
| 2003-06-30 | $0.08B | $0.04B | 51.28% |
| 2003-03-31 | $0.08B | $0.04B | 48.68% |
| 2002-12-31 | $0.07B | $0.03B | 47.89% |
| 2002-09-30 | $0.07B | $0.03B | 46.97% |
| 2002-06-30 | $0.06B | $0.03B | 45.00% |
| 2002-03-31 | $0.05B | $0.02B | 42.59% |
| 2001-12-31 | $0.05B | $0.02B | 42.31% |
| 2001-09-30 | $0.05B | $0.02B | 42.55% |
| 2001-06-30 | $0.04B | $0.02B | 40.91% |
| 2001-03-31 | $0.04B | $0.01B | 38.89% |
| 2000-12-31 | $0.03B | $0.01B | 29.63% |
| 2000-06-30 | $0.01B | $0.01B | 50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $173.357B | $10.065B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.946B | 23.74 |
| IDEXX Laboratories (IDXX) | United States | $51.473B | 49.32 |
| Edwards Lifesciences (EW) | United States | $45.675B | 30.63 |
| Alcon (ALC) | Switzerland | $38.991B | 26.28 |
| IQVIA Holdings (IQV) | United States | $31.930B | 17.25 |
| Mettler-Toledo (MTD) | United States | $28.060B | 32.10 |
| DexCom (DXCM) | United States | $27.289B | 37.62 |
| STERIS (STE) | Ireland | $24.749B | 25.02 |
| Waters (WAT) | United States | $22.705B | 30.02 |
| Coloplast (CLPBY) | Denmark | $17.601B | 26.93 |
| Hologic (HOLX) | United States | $16.701B | 17.48 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.912B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.959B | 11.58 |
| Penumbra (PEN) | United States | $13.355B | 93.94 |
| Globus Medical (GMED) | United States | $11.752B | 24.67 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.474B | 23.95 |
| Glaukos (GKOS) | United States | $6.463B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.024B | 19.14 |
| Teleflex (TFX) | United States | $4.792B | 7.64 |
| TransMedics (TMDX) | United States | $4.616B | 54.68 |
| LivaNova (LIVN) | United Kingdom | $3.635B | 19.63 |
| Integer Holdings (ITGR) | United States | $3.029B | 14.22 |
| Veracyte (VCYT) | United States | $2.861B | 32.60 |
| Elekta AB (EKTAY) | Sweden | $2.241B | 20.97 |
| UFP Technologies (UFPT) | United States | $2.062B | 27.22 |
| Alphatec Holdings (ATEC) | United States | $2.053B | 0.00 |
| Artivion (AORT) | United States | $1.876B | 86.07 |
| Nihon Kohden (NHNKY) | Japan | $1.855B | 20.47 |
| AxoGen (AXGN) | United States | $1.611B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.606B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.406B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.300B | 0.00 |
| IRadimed (IRMD) | United States | $1.221B | 58.16 |
| OPKO Health (OPK) | United States | $0.952B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.877B | 4.75 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.677B | 13.51 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.603B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.576B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.549B | 0.00 |
| NeuroPace (NPCE) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.42 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.435B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.418B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.383B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.331B | 55.12 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.310B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.226B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.177B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.168B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.160B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.144B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.118B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| Solana (HSDT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Accuray (ARAY) | United States | $0.070B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.044B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Envoy Medical (COCH) | United States | $0.014B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |